ANI Pharmaceuticals, Inc.
USD75.23
+0.58 (+0.78%)
CEO
Nikhil Lalwani
IPO Date
2000-05-05
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$74.24
Prev. Close
$74.65
Day Low
$73.54
Day High
$75.85
52W Low
$59.61
52W High
$99.50
Market Cap
$1.71B
Volume
0.25M
| 55,000 |
| $77.57 |
| 13 May 2026 | Gutwerg Ori | SVP, GENERICS | S-Sale | Disposed | 2,772 | $79.50 |
| 13 May 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S-Sale | Disposed | 500 | $78.16 |
| 13 May 2026 | Walsh Patrick D | director | S-Sale | Disposed | 3,973 | $80.75 |
| 13 May 2026 | Walsh Patrick D | director | S-Sale | Disposed | 10,000 | $80.63 |
| 13 Apr 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S-Sale | Disposed | 500 | $77.95 |
| 13 Mar 2026 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | S-Sale | Disposed | 4,772 | $74.91 |
| 13 Mar 2026 | Mutz Christopher | HEAD OF RARE DISEASE | S-Sale | Disposed | 3,162 | $71.64 |
| 13 Mar 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S-Sale | Disposed | 500 | $72.62 |